The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 26th 2024
Amgen’s MariTide achieved up to 20% average weight loss at 52 weeks without hitting a plateau in individuals with obesity or overweight.
November 16th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Fall Prevention Programs Ineffective at Reducing Falls, Injuries in Older Patients
November 5th 2020Results from a trial in England suggest fall prevention programs and interventions may not be reducing fall rates and fractures in older patients, but do point to other benefits from an exercise program.
DURATION-8: Exenatide and Dapagliflozin Effects Present 2 Years After Randomization
November 3rd 2020An extension study of the phase 3 trial indicate combination therapy with exenatide and dapagliflozin was effective 104 weeks after randomization in patients with type 2 diabetes and inadequate glycemic control despite metformin therapy.
Weight Loss Surgery Helps Prevent Secondary Cardiovascular Events for Severely Obese
October 29th 2020An analysis of data from European registries provide an overview of reductions in MACE and other benefits associated with metabolic surgery in severely obese patients with a history of myocardial infarction.
Terri Lipman, PhD, CRNP: Addressing Racial and Ethnic Disparities in Medicine
October 26th 2020The Assistant Dean of Community Engagement at the School of Nursing at the University of Pennsylvania offers perspective on addressing racial and ethnic disparities in medicine at an individual and societal level.